Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways.

Wanninger, Josef

Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways. [electronic resource] - American journal of physiology. Gastrointestinal and liver physiology Sep 2009 - G611-8 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1522-1547

10.1152/ajpgi.90644.2008 doi


Adiponectin--metabolism
Cell Culture Techniques
Cell Line, Tumor
Hepatocytes--drug effects
Humans
Interleukin-8--genetics
Mitogen-Activated Protein Kinase 1--antagonists & inhibitors
Mitogen-Activated Protein Kinase 3--antagonists & inhibitors
NF-kappa B--antagonists & inhibitors
Phosphorylation
Protein Kinase Inhibitors--pharmacology
RNA Interference
RNA, Messenger--metabolism
Receptors, Adiponectin--genetics
Recombinant Proteins--metabolism
STAT3 Transcription Factor--antagonists & inhibitors
Signal Transduction
Time Factors
Up-Regulation
p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors